Sugi Predict

Sugi Predict / Compounds / SCHEMBL10116352

SCHEMBL10116352

SCHEMBL10116352

Cc1cc(NC(=O)c2ccc(NS(=O)(=O)C(C)(C)C)cc2)cc2c1C(C)CC2

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 5/20 0.41
▸ MAPT P10636 4/20 0.41
▸ MEN1 O00255 4/20 0.41
▸ ALDH1A1 P00352 4/20 0.41
▸ KDM4E B2RXH2 2/20 0.41
▸ HTT P42858 1/20 0.41
▸ LMNA P02545 2/20 0.40
▸ RAB9A P51151 6/20 0.40
▸ NPC1 O15118 5/20 0.40
▸ NFKB1 P19838 1/20 0.40
▸ NFKB2 Q00653 1/20 0.40
▸ RELA Q04206 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ BRD4 O60885 2/20 0.38
▸ THRB P10828 1/20 0.38
▸ MCHR1 Q99705 1/20 0.37
▸ PTGER4 P35408 1/20 0.37
▸ NR1H4 Q96RI1 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10116630 0.86 RAB9A (0.40) KMT2AMAPTMEN1ALDH1A1KDM4E
SCHEMBL14424306 0.80 RAB9A (0.39) KMT2AMAPTMEN1ALDH1A1LMNA
SCHEMBL13565056 0.80 CA1 (0.33) MAPTALDH1A1KDM4ELMNARAB9A
SCHEMBL14424841 0.76 RAB9A (0.39) KMT2AMAPTMEN1ALDH1A1HTT
SCHEMBL10116372 0.76 HPGD (0.45) KMT2AMAPTMEN1ALDH1A1KDM4E
SCHEMBL10116282 0.76 HPGD (0.48) KMT2AMAPTMEN1ALDH1A1KDM4E
SCHEMBL10114487 0.75 RAB9A (0.66) KMT2AMAPTMEN1ALDH1A1KDM4E
SCHEMBL10116240 0.75 MEN1 (0.55) KMT2AMAPTMEN1ALDH1A1KDM4E
SCHEMBL12882673 0.74 THRB (0.46) KMT2AMAPTMEN1ALDH1A1KDM4E
SCHEMBL10115158 0.73 ALDH1A1 (0.38) KMT2AMAPTMEN1ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8115027-B2 NPY Y5 antagonist SHIONOGI & CO., LTD. (JP) 2012-02-14 — — US disclosed
US-8115027-B2 NPY Y5 antagonist SHIONOGI & CO., LTD. (JP) 2012-02-14 — — US disclosed
US-20110039802-A1 NPY Y5 ANTAGONIST KAWANISHI YASUYUKI 2011-02-17 — — US disclosed
US-20100292500-A1 NPY Y5 ANTAGONIST KAWANISHI YASUYUKI 2010-11-18 — — US disclosed
US-20100292500-A1 NPY Y5 ANTAGONIST KAWANISHI YASUYUKI 2010-11-18 — — US disclosed
US-7781461-B2 NPY Y5 antagonist KAWANISHI YASUYUKI 2010-08-24 — — US disclosed
US-7781461-B2 NPY Y5 antagonist KAWANISHI YASUYUKI 2010-08-24 — — US disclosed
US-7265130-B2 NPY Y5 antagonist SHIONOGI & CO., LTD. (JP) 2007-09-04 — — US disclosed
US-20070015762-A1 NPY Y5 antagonist KAWANISHI YASUYUKI 2007-01-18 — — US disclosed
US-20070015762-A1 NPY Y5 antagonist KAWANISHI YASUYUKI 2007-01-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070015762-A1 NPY Y5 antagonist NPY5R, NPY1R, NPY2R KMT2A 2912/4885MAPT 3602/4885MEN1 2876/4885
US-20100292500-A1 NPY Y5 ANTAGONIST NPY5R, NPY1R, NPY2R KMT2A 2768/4885MAPT 3367/4885MEN1 2932/4885
US-20110039802-A1 NPY Y5 ANTAGONIST NPY5R, NPY1R, NPY2R KMT2A 2953/4885MAPT 3683/4885MEN1 2926/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.